RGEN · Repligen Corporation

Repligen Corporation delivered strong Q1 2026 results with revenue of $194 million, reflecting 15% reported growth and 11% organic growth over the prior year quarter's $169 million. This performance exceeded expectations, driven by effective execution across the business as noted by CEO Olivier Loeillot. GAAP income from operations rose to $16 million from $7 million, while adjusted operating income increased to $30 million from $23 million, delivering 160 basis points of margin expansion to 15.4%. GAAP EPS improved 50% to $0.15 and adjusted EPS rose 23% to $0.48. Gross margins also expanded, with GAAP at 55.7% (up from 54.0%) and adjusted at 55.5% (up from 53.7%). Cash and equivalents plus marketable securities stood at $785 million at quarter-end, up from $768 million at year-end 2025. The company reiterated full-year 2026 organic revenue growth guidance of 9%-13% on reported revenue of $803-$833 million, while raising adjusted EPS guidance to $1.97-$2.05, reflecting a modest FX tailwind offset by the Polymem divestiture headwind. Strategic moves included divesting the non-core Polymem filtration business on March 30, which generated $7 million revenue and an operating loss in 2025, launching a Transformation Office for margin optimization and site rationalization, and signing a China OEM partnership to boost APAC competitiveness. These actions underscore focus on profitable growth and infrastructure optimization amid robust order trends.